What is it about?

Serum levels of AGEs and sRAGE have an important role in the pathogenesis and complications of T2DM, but do they actually correlated with the markers of disease progression? This article evaluates if there is any correlation between the changes in AGEs and sRAGE in relation to the changes in the biomarkers of T2DM.

Featured Image

Read the Original

This page is a summary of: Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitus, Diabetes & Metabolic Syndrome Clinical Research & Reviews, June 2019, Elsevier,
DOI: 10.1016/j.dsx.2019.06.019.
You can read the full text:

Read

Contributors

The following have contributed to this page